VBI Vaccines, Inc. - Ordinary Shares (VBIV) earnings
Quarterly and annual VBIV reports and results, each read against the price at its own news timestamp. Back to the VBIV overview →
6 measured VBIV earnings events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q VBI Vaccines Inc/BC For: Mar 31 | SEC filing · Form 10-Q | +0.42% | +0.35% | |
| VBI Vaccines Reports First Quarter 2024 Financial Results | Press release | +0.42% | +0.35% | |
| Form 10-K VBI Vaccines Inc/BC For: Dec 31 | SEC filing · Form 10-K | +1.35% | +10.71% | |
| Form NT 10-K VBI Vaccines Inc/BC For: Dec 31 | SEC filing · Form NT | -0.10% | +3.02% | |
| Form 10-Q VBI Vaccines Inc/BC For: Sep 30 | SEC filing · Form 10-Q | +0.30% | -5.18% | |
| VBI Vaccines Reports Third Quarter 2023 Financial Results | Press release | +0.30% | -5.18% |
Keep exploring
More VBIV: analyst actions → · SEC filings → · VBIV overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| UNITED HEALTH PRODUTS INC (UEEC) | 53 | 0.00% | 43% |
| EASTON PHARMS INC (EAPH) | 52 | 0.00% | 34% |
| Crescent Biopharma, Inc. (CBIO) | 51 | -1.24% | 50% |
| Careview Communications, Inc. (CRVW) | 51 | 0.00% | 12% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.